Daily uptake of mycotoxins - TDI might not be protective for nursed infants

被引:22
作者
Degen, G. H. [1 ]
Partosch, F. [2 ]
Munoz, K. [3 ]
Gundert-Remy, U. [4 ]
机构
[1] TU Dortmund IfADo, Leibniz Inst Arbeitsforsch, Ardeystr 67, D-44139 Dortmund, Germany
[2] Fed Environm Agcy, Schichauweg 58, D-12307 Berlin, Germany
[3] Univ Koblenz Landau, Inst Environm Sci, Fortstr 7, D-76829 Landau, Germany
[4] Univ Med Berlin, Charite, Inst Clin Pharmacol & Toxicol, Charitepl 1, D-10117 Berlin, Germany
关键词
Breast milk; Infants; Mycotoxins; Tolerable daily intake; HUMAN BREAST-MILK; OCHRATOXIN-A; RISK-ASSESSMENT; CURRENT STATE; EXPOSURE; ZEARALENONE; AFLATOXIN; PHARMACOKINETICS; METABOLITES; TISSUE;
D O I
10.1016/j.toxlet.2017.06.002
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Exclusive breast feeding is recommended by international bodies for the first six months of life. Because of the presence of contaminants, breast feeding might lead to toxicologically relevant exposure of the nursed child. Exposure towards mycotoxins is of specific interest because of their widespread occurrence in food and of their toxicological profile. We calculated the relationship between maternal intake at the level of the existing TDIs and the exposure in the nursed infants of several mycotoxins to evaluate whether maternal exposure at the TDI is also safe for the nursed infant. If published information was not available we used in silico methods for estimating toxicokinetic parameters and the lactational transfer. A single dose and a continuous daily intake scenario were considered. Maternal intake at the TDI exceeds the age-adjusted TDI (TDI/3) values for infants in case of deoxynivalenol and patulin in the single dose scenario. Exceedance is particularly pronounced for ochratoxin A in the continuous daily intake scenario (29.2 fold above the child adjusted TDI). According to published data in infants impaired kidney function may result from this exceedance. When setting a TDI, the safety of the exclusively nursed infant should be considered in the continuous daily intake scenario.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 49 条
[41]   Ionization-Specific Analysis of Human Intestinal Absorption [J].
Reynolds, Derek P. ;
Lanevskij, Kiril ;
Japertas, Pranas ;
Didziapetris, Remigijus ;
Petrauskas, Alanas .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (11) :4039-4054
[42]   Evaluation of mycotoxins and their metabolites in human breast milk using liquid chromatography coupled to high resolution mass spectrometry [J].
Rubert, Josep ;
Leon, Nuria ;
Saez, Carmen ;
Martins, Claudia P. B. ;
Godula, Michal ;
Yusa, Vicent ;
Manes, Jordi ;
Soriano, Jose Miguel ;
Soler, Carla .
ANALYTICA CHIMICA ACTA, 2014, 820 :39-46
[43]   General approach for the calculation of tissue to plasma partition coefficients [J].
Schmitt, Walter .
TOXICOLOGY IN VITRO, 2008, 22 (02) :457-467
[44]   Disposition, Oral Bioavailability, and Tissue Distribution of Zearalenone in Rats at Various Dose Levels [J].
Shin, Beom Soo ;
Hong, Seok Hyun ;
Bulitta, Juergen B. ;
Hwang, Sang Wook ;
Kim, Hyoung Jun ;
Lee, Jong Bong ;
Yang, Seung Du ;
Kim, Ji Eun ;
Yoon, Hae-Seong ;
Kim, Do Jung ;
Yoo, Sun Dong .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2009, 72 (21-22) :1406-1411
[45]   Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans [J].
Studer-Rohr, I ;
Schlatter, J ;
Dietrich, DR .
ARCHIVES OF TOXICOLOGY, 2000, 74 (09) :499-510
[46]  
U. S. Environmental Protection Agency, 2011, EXP FACT HDB
[47]   Biomonitoring of Mycotoxins in Human Breast Milk: Current State and Future Perspectives [J].
Warth, Benedikt ;
Braun, Dominik ;
Ezekiel, Chibundu N. ;
Turner, Paul C. ;
Degen, Gisela H. ;
Marko, Doris .
CHEMICAL RESEARCH IN TOXICOLOGY, 2016, 29 (07) :1087-1097
[48]   Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy [J].
Woo, Chit Shing Jackson ;
El-Nezami, Hani .
TOXINS, 2016, 8 (04)
[49]  
World Health Organization (WHO), 2021, Fact sheet